Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The gradual deterioration of cognitive functions in Alzheimer's disease is paralleled by a hierarchical progression of amyloid-beta and tau brain pathology. Recent findings indicate that toxic oligomers of amyloid-beta may cause propagation of pathology in a prion-like manner, although the underlying mechanisms are incompletely understood. Here we show that small extracellular vesicles, exosomes, from Alzheimer patients' brains contain increased levels of amyloid-beta oligomers and can act as vehicles for the neuron-to-neuron transfer of such toxic species in recipient neurons in culture. Moreover, blocking the formation, secretion or uptake of exosomes was found to reduce both the spread of oligomers and the related toxicity. Taken together, our results imply that exosomes are centrally involved in Alzheimer's disease and that they could serve as targets for development of new diagnostic and therapeutic principles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, in damaged environments, like AD, exosomes are involved in the transportation of damaging proteins like Aβ and Tau [116].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [116]
The cited source says what the claim attributes to it.
In the citing paper
“A previous study has shown that sEVs isolated from the brains of AD patients contain elevated levels of Aβ oligomers [141].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“These EVs have been discovered as possible transporters for transferring toxic protein species from neuron to neuron, as has been shown in vitro.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“oAβ42 has been detected within neuronal exosomes.”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Data from cells treated with these exosomes also revealed that the exosomes facilitated delivery of oAβ42 and induced toxic effects [24].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200 · cited 1×
“These findings suggest that exosomes might be the main mediator of the pathogenic progression in AD as was recently suggested for dementia with Lewy bodies [41].”
BackgroundRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346 · cited 2×
“It has been suggested that exosomal release may provide an alternative disposal mechanism to lysosomal degradation of oAβ [5] or other proteins that are resistant to degradation [55].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The nature of the propagating species has not been established, although several studies have indicated a particularly pathogenic role of soluble oAβ on synaptic and cellular functions and structure [13, 32, 50, 60].”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“1 3 Aß, tau and α-synuclein [12, 17, 46, 59] and can propagate tau pathology [4].”
BackgroundAlzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 2×
“Accordingly, exosomes from blood [22], CSF [17, 49] and cell cultures [46] have been shown to contain monomeric Aβ and tau, but so far, no study has addressed the presence of oAβ in exosomes from human AD brains.”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · cited 1×
“Here dystrophic neurites with neurite beading and loss of neurite branching were identified, known early signs of neurodegeneration [51].”
Background
Research works printed but not linked: 1
- Tucker S, Möller C, Tegerstedt K, Lord A, Laudon H, Sjödahl J, Söderberg L, Spens E, Sahlin C, Waara ER et al (2015) The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. JAD 43:575–588. https://doi.org/10.3233/JAD-140741 · DOI · Paper page
Cited by
Items 201–300 of 529
He, Y., Kan, W., Li, Y., Hao, Y., Huang, A., Gu, H., Wang, M., Wang, Q., Chen, J., Sun, Z., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.289 · Cited by 31
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03475-z · Cited by 28
Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies
Mohan, M., Okeoma, C. M., & Sestak, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155407 · Cited by 31
Metals in ALS TDP-43 Pathology
Koski, L., Ronnevi, C., Berntsson, E., Wärmländer, S. K. T. S., & Roos, P. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212193 · Cited by 34
“The main toxic species in many proteinopathies appears not to be the large protein aggregates but rather small soluble intermediate oligomers that form along the aggregation pathways [44,46,48,56].”
BackgroundThe Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease
Zhao, Y., Gu, Y., Zhang, Q., Liu, H., & Liu, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051883 · Cited by 31
“Furthermore, exosomes containing APP can spread to normal neurons in a dose-dependent manner [37], inhibiting the formation, secretion, or uptake of exosomes that could decrease the spread of toxic oligomers [38].”
BackgroundSackmann, C., & Hallbeck, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63398-6 · Cited by 27
Self-citationPait, M. C., Kaye, S. D., Su, Y., Kumar, A., Singh, S., Gironda, S. C., Vincent, S., Anwar, M., Carroll, C. M., Snipes, J. A., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12398 · Cited by 34
Roles, Functions, and Pathological Implications of Exosomes in the Central Nervous System
Spinelli, S., Tripodi, D., Corti, N., Zocchi, E., Bruschi, M., Leoni, V., & Dominici, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031345 · Cited by 29
“Exosomes are implicated in the propagation of toxic A β and tau between neurons, furthering neuronal death and the spread of pathological proteins [66,67].”
Role of Extracellular Vesicles in Substance Abuse and HIV-Related Neurological Pathologies
Odegaard, K. E., Chand, S., Wheeler, S. P., Tiwari, S., Flores, A., Hernandez, J. B., Savine, M., Gowen, A. M., Pendyala, G., & Yelamanchili, S. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186765 · Cited by 26
Dunlop, R. A., Banack, S. A., & Cox, P. A. (2023) · RNA Biology · doi:10.1080/15476286.2023.2198805 · Cited by 28
Inter-neuronal signaling mediated by small extracellular vesicles: wireless communication?
Torres, D. N., & Lee, S. H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1187300 · Cited by 30
Russell, A. E., Jun, S., Sarkar, S., Geldenhuys, W. J., Lewis, S. E., Rellick, S. L., & Simpkins, J. W. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00051 · Cited by 28
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Zhang, Y., Yuan, Z. K., Zhang, J., Gao, Y., Gao, X., Li, S., Cui, C., & Yang, G. (2024) · Journal of Proteomics · doi:10.1016/j.jprot.2024.105279 · Cited by 26
Han, J., Zhang, X., Kang, L., & Guan, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03443-1 · Cited by 29
Zhuang, L., You, Q., Su, X., Chang, Z., Ge, M., Mei, Q., Li, Y., Dong, W., & Li, L. (2023) · Sensors · doi:10.3390/s23073508 · Cited by 25
“Subsequently, exosomes have been successively found to play an important role in cellular communication, tumorigenesis, and the development of neurodegenerative diseases [3,4].”
BackgroundThe role of exosomes in adult neurogenesis: implications for neurodegenerative diseases
Yu, Z., Teng, Y., Yang, J., & Yang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379036 · Cited by 28
Manolopoulos, A., Delgado‐Peraza, F., Mustapić, M., Pucha, K. A., Nogueras‐Ortiz, C. J., Daskalopoulos, A., Knight, D. D., Leoutsakos, J., Oh, E. S., Lyketsos, C. G., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1254834 · Cited by 28
Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation
Aljohani, M. A. (2025) · Medicina · doi:10.3390/medicina61111930 · Cited by 28
Bécot, A., Volgers, C., & van Niel, G. (2020) · Biomedicines · doi:10.3390/biomedicines8080272 · Cited by 24
“Firstly, the transfer of exosomes from cell-based AD models or derived from AD patients to naïve neurons/mice facilitates Tau and Aβ oligomer spreading [161,162] as well as neurotoxicity and neurogenesis alterations [163].”
BackgroundGiaimo, R. D., Penna, E., Pizzella, A., Cirillo, R., Perrone‐Capano, C., & Crispino, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239133 · Cited by 27
“only contain amyloid-beta oligomers but also, in vitro, are able to spread these oligomers from neuron to neuron [53].”
BackgroundNeurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges
Noor, A., Zafar, S., & Zerr, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031085 · Cited by 26
“Exosome-mediated transport can then spread the oligomeric species to other parts of the affected organ, spreading the pathology [10,11].”
BackgroundMicrofluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
Prasanna, P., Rathee, S., Rahul, V., Mandal, D., Goud, M. S. C., Yadav, P., Hawthorne, S. J., Sharma, A., Gupta, P. K., Ojha, S. K., et al. (2021) · Life · doi:10.3390/life11101022 · Cited by 28
Picca, A., Ferri, E., Calvani, R., Coelho‐Júnior, H. J., Marzetti, E., & Arosio, B. (2022) · Nutrients · doi:10.3390/nu14122406 · Cited by 28
Mentor, S., & Fisher, D. W. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.938315 · Cited by 25
Cáceres, C., Heusser, B., Garnham, A., & Moczko, E. (2023) · Cells · doi:10.3390/cells12232669 · Cited by 27
“Mitochondrial-targeted therapies aim at improving mitochondrial function and reducing accumulation of ROS through targeting specific mitochondrial components, such as the electron transport chain or mPTP.”
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson’s Disease
Longoni, B., Fasciani, I., Kolachalam, S., Pietrantoni, I., Marampon, F., Petragnano, F., Aloisi, G., Coppolino, M. F., Rossi, M., Scarselli, M., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191113103537 · Cited by 25
Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer
Wei, Y., Du, X., Guo, H., Han, J., & Liu, M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1517965 · Cited by 26
The promise of exosome applications in treating central nervous system diseases
Mattingly, J., Li, Y., Bihl, J. C., & Wang, J. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13743 · Cited by 25
Alvarez, X. A., Winston, C. N., Barlow, J. W., Sarsoza, F. M., Álvarez, I., Aleixandre, M., Linares, C., García-Fantini, M., Kastberger, B., Winter, S., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220575 · Cited by 32
“Recent investigations in AD demonstrated that circulating NDEV contain pathological molecules such as A 1-42 (A 42), total and phosphorylated tau, and synaptic proteins [10–12]; which may contribute to the spread of AD pathology [9, 13, 14], and can serve as effective disease biomarkers [7–9, 15, 16].”
BackgroundZhang, C., Yang, X., Jiang, T., Yan, C., Xu, X., & Chen, Z. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121624 · Cited by 25
Tunneling nanotubes: A novel pharmacological target for neurodegenerative diseases?
Wang, X.-T., Sun, H., Chen, N.-H., & Yuan, Y.-H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105541 · Cited by 22
Mustafa, M., Musselman, D. L., Jayaweera, D. T., Ferreira, A. D. F., Marzouka, G. R., & Dong, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011170 · Cited by 26
“These biomarkers were found to be elevated in NDEs from AD patients compared to controls, with abnormalities present even in preclinical stages of AD [98].”
BackgroundRole of dietary and nutritional interventions in ceramide-associated diseases
Wang, S., Jin, Z., Wu, B., Morris, A. J., & Deng, P. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100726 · Cited by 27
Central Nervous System-Derived Extracellular Vesicles as Biomarkers in Alzheimer’s Disease
Yu, Y., Wang, Z., Chai, Z., Ma, S., Li, A., & Li, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178272 · Cited by 26
“Notably, sEVs from AD patients’ brains carry elevated amounts of A β oligomers and facilitate the transfer of this toxic cargo between neurons [40].”
Central Nervous System Cell‐Derived Exosomes in Neurodegenerative Diseases
Tian, Y., Fu, C., Wu, Y., Lu, Y. W., Liu, X., & Yunling, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9965564 · Cited by 24
“not only uncovered that the exosomes isolated from AD patients contain Aβ and are neurotoxic but also carried out a coculture experiment using SHSY5Y which showed Aβ spread via exosomes and blocking formation, secretion, or uptake of exosomes could significantly reduce the toxicity in vitro [25].”
BackgroundResearch Progress on the Pathogenesis, Diagnosis, and Drug Therapy of Alzheimer’s Disease
Yang, Y., & Qiu, L. (2024) · Brain Sciences · doi:10.3390/brainsci14060590 · Cited by 23
“By detecting elevated levels of A β and Tau proteins in exosomes, AD can be detected ten years earlier than clinical diagnosis with an accuracy rate of 96% [120,122].”
BackgroundKoinuma, S., Shimozawa, N., Yasutomi, Y., & Kimura, N. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.022 · Cited by 23
Ledreux, A., Thomas, S., Hamlett, E. D., Trautman, C. W., Gilmore, A., Hager, E. R., Paredes, D., Margittai, M., Fortea, J., & Granholm, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173931 · Cited by 23
Kotarba, S., Kozłowska, M., Scios, M., Saramowicz, K., Barczuk, J., Granek, Z., Siwecka, N., Wiese, W., Golberg, M., Galita, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910797 · Cited by 26
Reho, P., Kalia, V., Jackson, G. L., Wang, F., Eiten, E., Brennan, K. J. M., Brickman, A. M., Mayeux, R. P., Miller, G. W., Vardarajan, B. N., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70050 · Cited by 25
Neuron-derived extracellular vesicle-based diagnostics for Tau and Alzheimer’s disease
Chinnathambi, S., Kumarappan, M., Malik, S., Velmurugan, G., & Chandrashekar, M. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2024.12.006 · Cited by 21
Rational design of extracellular vesicles for targeted drug delivery across physiological barriers
Baby, H. M., Zhang, H., Selvadoss, A., Pathrikar, T. V., & Bajpayee, A. G. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102920 · Cited by 24
Anakor, E., Milla, V., Connolly, O., Martinat, C., Pradat, P., Dumonceaux, J., Duddy, W. J., & Duguez, S. (2022) · Cells · doi:10.3390/cells11050845 · Cited by 24
Exosomes in multiple sclerosis and Alzheimer's disease – Adversary and ally
Tang, N. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100665 · Cited by 22
“[54] Plasma neuronal EVs pTau-181, pTau-396, A β 42 pTau seeding and propagation: 1) pTau-181, pTau-396 and A β 42 were all higher in AD.”
BackgroundKim, B., Kang, Y., Mendelson, F. E., Hayes, J. M., Savelieff, M. G., Nagrath, S., & Feldman, E. L. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12340 · Cited by 22
Hotspots and trends of microglia in Alzheimer's disease: a bibliometric analysis during 2000–2022
Zhang, L., Yao, Q., Hu, J., Qiu, B., Xiao, Y., Zhang, Q., Zeng, Y., Zheng, S., Zhang, Y., Wan, Y., et al. (2024) · European journal of medical research · doi:10.1186/s40001-023-01602-9 · Cited by 24
Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer’s Disease
Rosas-Hernández, H., Cuevas, E., Raymick, J. B., Robinson, B. L., Ali, S. F., Hanig, J. P., & Sarkar, S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190321155422 · Cited by 23
Khedher, M. R. B., Haddad, M., Laurin, D., & Ramassamy, C. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12124 · Cited by 22
The Microfluidic Toolbox for Analyzing Exosome Biomarkers of Aging
DeCastro, J., Littig, J., Chou, P. P., Mack‐Onyeike, J., Srinivasan, A., Conboy, M. J., Conboy, I. M., & Aran, K. (2021) · Molecules · doi:10.3390/molecules26030535 · Cited by 22
“Sinha et al., 2018 highlighted that exosomes isolated from the brain of deceased AD patients contain increased levels of amyloid-beta oligomers (oAβ), confirmed with exosomal and oAβ immunofluorescence co-localization.”
BackgroundResultMartins, T. S., Marçalo, R., Ferreira, M., Vaz, M., Silva, R. M., Rosa, I. M., Vogelgsang, J. S., Wiltfang, J., Silva, O. A. B. D. C. E., & Henriques, A. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083933 · Cited by 23
Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 25
Asgarshamsi, M. H., Fassihi, A., Hassanzadeh, F., Saghaei, L., Attar, A. M., & Mohammad‐Beigi, H. (2020) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.305187 · Cited by 20
“They are often produced from the interaction of toxic protein configurations with other native copies of the same protein and catalysis of their transition state into a toxic state (3).”
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIP
Pal, A., Gori, S. S., Yoo, S., Thomas, A. G., Wu, Y., Friedman, J., Tenora, L., Bhasin, H., Alt, J., Haughey, N. J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00562 · Cited by 21
Lin, L., Li, C., Zhang, L., Zhang, Y., Gao, L., Li, T., Jin, L., Shen, Y., & Ren, D. (2023) · Food & Function · doi:10.1039/d3fo01602a · Cited by 20
Mousavi, H., Rimaz, M., & Zeynizadeh, B. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00055 · Cited by 22
Clinical implications of extracellular vesicles in neurodegenerative diseases
Vinaiphat, A., & Sze, S. K. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1657407 · Cited by 20
Counil, H., & Krantic, S. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191237 · Cited by 21
Membrane interaction to intercellular spread of pathology in Alzheimer’s disease
Valappil, D. K., Mini, N. J., Dilna, A., & Nath, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.936897 · Cited by 19
Proust, A. M., Barat, C., Lebœuf, M., Drouin, J., Gagnon, M., Vanasse, F., & Tremblay, M. J. (2020) · Glia · doi:10.1002/glia.23833 · Cited by 21
“It is already known that exosomes can mediate neuron-to-neuron propagation of Aβ (Sardar Sinha et al., 2018).”
BackgroundNakagawa, Y., & Yamada, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01234-3 · Cited by 20
Sackmann, C., Sackmann, V., & Hallbeck, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00540 · Cited by 23
Self-citationPopescu-Drigă, M. V., Cătălin, B., Olaru, D. G., Słowik, A., Plesnila, N., Hermann, D. M., & Popa‐Wagner, A. (2021) · Biomedicines · doi:10.3390/biomedicines9091226 · Cited by 20
Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
Izco, M., Carlos, E., & Alvarez‐Erviti, L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105651 · Cited by 19
Li, X., Chen, J., Yang, Y., Cai, H., Ao, Z., Xing, Y., Li, K., Yang, K., Guan, W., Friend, J., et al. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-00916-4 · Cited by 17
Monitoring neurodegeneration through brain-derived extracellular vesicles in biofluids
Torrini, F., Gil-García, M., Cardellini, J., Frigerio, R., Basso, M., Gori, A., & Arosio, P. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.03.006 · Cited by 21
Gonul, C. P., Karaçiçek, B., & Genç, Ş. (2025) · Developmental Neurobiology · doi:10.1002/dneu.22984 · Cited by 19
Ghosh, M., Bayat, A., & Pearse, D. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157246 · Cited by 20
Ma, K., Zheng, Z.-R., & Meng, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041459 · Cited by 20
“Blocking the formation, secretion, or uptake of EVs was found to reduce both the spread of oligomers and associated toxicity [78,172].”
BackgroundBir, A., Ghosh, A., Chauhan, A., Saha, S., Saini, A. K., Bisaglia, M., & Chakrabarti, S. (2024) · Antioxidants · doi:10.3390/antiox13030316 · Cited by 20
“Consistent with this notion, another study demonstrated the cytotoxic properties of exosomes isolated from postmortem AD brains [145].”
The Role of Aptamer Loaded Exosome Complexes in the Neurodegenerative Diseases
Sekhon, S. S., Ahn, G., Park, G., Park, D. Y., Lee, S., Ahn, J., & Kim, Y. (2019) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-019-0392-6 · Cited by 18
Early prediction of cerebral-cardiac syndrome after ischemic stroke: the PANSCAN scale
Lian, H., Xu, X., Shen, X.-H., Chen, J., Mao, D., Zhao, Y., & Yao, M. (2020) · BMC Neurology · doi:10.1186/s12883-020-01833-x · Cited by 17
Reduced retromer function results in the accumulation of amyloid-beta oligomers
Ansell-Schultz, A., Reyes, J. F., Samuelsson, M., & Hallbeck, M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.09.003 · Cited by 18
Self-citationFigueroa‐Hall, L. K., Burrows, K., Alarbi, A. M., Hannafon, B. N., Hladik, C., Tan, C., Ramesh, R., Stewart, J. L., Risbrough, V. B., Paulus, M. P., et al. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70035 · Cited by 18
Zhou, Q., Zhao, H., Ma, C., Huang, L., Liu, J., Guo, L., Peng, C. Y., & Xiong, L. (2022) · Organic Letters · doi:10.1021/acs.orglett.2c01587 · Cited by 16
Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis
Pereira, M., Ribeiro, D. R., Berg, M., Tsai, A. P., Dong, C., Nho, K. T., Kaiser, S., Moutinho, M., & Soares, A. R. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166857 · Cited by 20
Pulliam, L., Sun, B., McCafferty, E., Soper, S. A., Witek, M. A., Hu, M., Ford, J. M., Song, S., Kapogiannis, D., Glesby, M. J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073830 · Cited by 17
Ashique, S., Kumar, N., Mishra, N., Muthu, S., Rajendran, R. L., Chandrasekaran, B., Obeng, B. F., Hong, C. M., Krishnan, A., Ahn, B., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155451 · Cited by 18
The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
Daksh, R., Mathew, M. S., Bosco, A. M., Sojan, C., Tom, A. A., Bojja, S. L., & Nampoothiri, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151526 · Cited by 18
Liu, X., Wang, H., Tian, X., Luo, Y., Ma, M., Zheng, Z., Wang, Y., Feng, S., Wang, Q., Xu, Z. F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03488-2 · Cited by 21
Alpaugh, M., Denis, H. L., & Cicchetti, F. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01350-4 · Cited by 17
Pazzaglia, S., Tanno, B., Stefano, I. D., Giardullo, P., Leonardi, S., Merla, C., Babini, G., Cagatay, S. T., Mayah, A., Kadhim, M. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042169 · Cited by 16
KIBRA regulates amyloid β metabolism by controlling extracellular vesicles secretion
Han, X., Wang, C., Song, L., Wang, X., Tang, S. H., Hou, T., Liu, C., Liang, X., Qiu, C., Wang, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103980 · Cited by 15
Zhu, M., Ma, X., Huang, J., Fangguo, L., Chen, Y., Hu, J., Cheng, L., Zhang, B., Liu, W., & Li, L. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.104998 · Cited by 17
Berntsson, E., Vosough, F., Svantesson, T., Pansieri, J., Iashchishyn, I. A., Ostojić, L., Dong, X., Paul, S., Jarvet, J., Roos, P. M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29901-5 · Cited by 18
Eckman, E. A., Clausen, D. M., Solé‐Domènech, S., Lee, C. W., Pereira, C. S., Domalewski, R. J., Nichols, M. R., & Pacheco‐Quinto, J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1318-23.2023 · Cited by 16
Halipi, V., Sasanian, N., Feng, J., Hu, J., Lubart, Q., Bernson, D., van Leeuwen, D., Ahmadpour, D., Sparr, E., & Esbjörner, E. K. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00655 · Cited by 17
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease
Martins, T. S., Ferreira, M., Magalhães, S., Leandro, K., de Almeida, L. P., Vogelgsang, J. S., Breitling, B., Hansen, N., Esselmann, H., Wiltfang, J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231239 · Cited by 20
Long Non-Coding RNAs and Alzheimer’s Disease: Towards Personalized Diagnosis
Mosquera-Heredia, M. I., Vidal, O. M., Morales, L. C., Silvera-Redondo, C. A., Barceló, E., Allegri, R., Arcos‐Burgos, M., Velez, J. I., & Garavito, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147641 · Cited by 16
“Furthermore, exosomes may create an environment conducive to amyloid fibril formation, thereby significantly influencing the pathogenesis of AD [14].”
BackgroundHuete-Acevedo, J., Mas‐Bargues, C., Arnal-Forné, M., Atencia-Rabadán, S., Sanz‐Ros, J., & Borrás, C. (2024) · Antioxidants · doi:10.3390/antiox13121493 · Cited by 16
Cavallaro, F., Nibali, S. C., Cubisino, S. A. M., Caruso, P., Zimbone, S., Infantino, I. R., Reina, S., Pinto, V. D., Messina, A. A., Giuffrida, M. L., et al. (2025) · Aging Cell · doi:10.1111/acel.70069 · Cited by 16
“Among different species, Aβ oligomers are regarded as highly neurotoxic, being able to accumulate also within the neurons, diffuse from one cell to another, and serve as seeds for aggregation (LaFerla et al. 2007; Gouras et al. 2000; Sardar Sinha et al. 2018; Domert et al. 2014).”
Elevated levels of extracellular vesicles in progranulin‐deficient mice and FTD‐GRN Patients
Arrant, A. E., Davis, S. E., Vollmer, R. M., Murchison, C., Mobley, J. A., Nana, A. L., Spina, S., Grinberg, L. T., Karydas, A. M., Miller, B. L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51242 · Cited by 17
Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes
Duggan, M. R., Lu, A., Foster, T. C., Wimmer, M. E., & Parikh, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.834775 · Cited by 16
“Evidence indicating the association between aggregate-prone proteins (i.e., Aβ, pTau) and age-related cognitive decline is abundant, with increasing data suggesting their spread between CNS cells can be facilitated through exosomes (Wang et al., 2017; Sardar Sinha et al., 2018).”
BackgroundThe Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Conceição, A. R., Marinatto, J., Pinheiro, L. S., Rody, T., & Felice, F. G. D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70209 · Cited by 16
“These findings illuminate the molecular pathways underlying the EV-mediated effects of PE on CNS function.”
InfluentialYu, Y., Gao, Y., Winblad, B., Tjernberg, L. O., & Schedin-Weiss, S. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-215008 · Cited by 12
“Intraluminal vesicles (ILVs) stored in MVBs, and subsequently released as exosomes [21], have been suggested to be one way by which A is secreted [22].”
Colvett, I., Saternos, H. C., Coughlan, C. M., Vielle, A., & Ledreux, A. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.07 · Cited by 18
Impact of Membrane Phospholipids and Exosomes on the Kinetics of Amyloid-β Fibril Assembly
Khursheed, A., & Viles, J. H. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168464 · Cited by 15
Autophagy and exosomes; inter-connected maestros in Alzheimer’s disease
Atya, H. B., Sharaf, N. M., Abdelghany, R. M., El-Helaly, S. N., & Taha, H. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01466-3 · Cited by 15
“They contribute to the dissemination of toxic forms of aggregated proteins like α-synuclein, β-amyloid, and misfolded SOD1, which are implicated in neurodegenerative diseases (Sharples et al. 2008; Danzer et al. 2012; Grad et al. 2014; Sardar Sinha et al. 2018).”
BackgroundExtracellular vesicles‐based theranostics for neurodegenerative diseases
Zhao, H., Zhu, L., Wang, C., & Yang, Y. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1993 · Cited by 17
Hermann, D. M., Wang, C., Yusuf, A. M., Herz, J., Doeppner, T. R., & Giebel, B. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251325039 · Cited by 22
Metadata
- Authors
- Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M.
- Affiliations
- Linköping University (SE)
- Uppsala University (SE)
- Corresponding author
- Hallbeck, Martin
- Venue
- Acta Neuropathologica
- Published
- 2018-06-13
- Volume
- 136
- Issue
- 1
- Pages
- 41-56
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6015111
- OpenAlex
- W2807776100
- Cited by
- 527
- References
- 60
- Citations by year
- 2026: 48 · 2025: 70 · 2024: 71 · 2023: 64 · 2022: 60 · 2021: 74 · 2020: 82 · 2019: 50 · 2018: 6
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Funders
- Vetenskapsrådet (523-2013-2735)
- Alzheimerfonden
- Hjärnfonden
- Hans-Gabriel och Alice Trolle Wachtmeister Stiftelse för Medicinsk forskning
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Knut och Alice Wallenbergs Stiftelse
- Demensförbundet
- Linköpings Universitet
- Region Östergötland
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, exosomes, amyloid-beta oligomers, prion-like propagation, extracellular vesicles, tau pathology, exosome secretion, exosome uptake, neurotoxicity
- MeSH terms
- Tsg101 Protein, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cell Line, Transformed, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, L-Lactate Dehydrogenase, Male, Membrane Proteins, Middle Aged, Neuroblastoma, Organic Chemicals, Peptide Fragments, Transcription Factors, Amyloid beta-Peptides, Culture Media, Conditioned, Coculture Techniques, Protein Transport, Pluripotent Stem Cells, Microscopy, Electron, Transmission, Exosomes, Endosomal Sorting Complexes Required for Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.